Erratum for the Research Article: “A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent” by N. Gioelli, F. Maione, C. Camillo, M. Ghitti, D. Valdembri, N. Morello, M. Darche, L. Zentilin, G. Cagnoni, Y. Qiu, M. Giacca, M. Giustetto, M. Paques, I. Cascone, G. Musco, L. Tamagnone, E. Giraudo, G. Serini

See allHide authors and affiliations

Science Translational Medicine  25 Jul 2018:
Vol. 10, Issue 451, eaau7326
DOI: 10.1126/scitranslmed.aau7326

Article Information

vol. 10 no. 451

Print ISSN: 
Online ISSN: 
  • .
Other Contributors: 
  • American Association for the Advancement of Science

Author Information


Article usage

Article usage: July 2018 to January 2020

Jul 2018017440
Aug 201803151
Sep 201801100
Oct 201801271
Nov 201801050
Dec 20180912
Jan 20190640
Feb 20190670
Mar 20190710
Apr 20190561
May 20190751
Jun 201901961
Jul 20190850
Aug 20190480
Sep 20190311
Oct 20190300
Nov 20190314
Dec 20190301
Jan 20200240

Stay Connected to Science Translational Medicine

Navigate This Article